Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7365-7375
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7365
Table 1 Baseline characteristics, n (%)
Variables
Total (n = 34)
CRT (n = 17)
Radiation (n = 17)
P value
Age (yr)0.275
Median (range)76.0 (72.0-80.0)77.0 (75.0-80.0)75.0 (72.0-80.0)
Age0.731
≤ 75 yr16 (47.1)7 (41.2)9 (52.9)
> 75 yr18 (52.9)10 (58.8)8 (47.1)
Gende1.000
Female5 (14.7)3 (17.6)2 (11.8)
Male29 (85.3)14 (82.4)15 (88.2)
Primary tumor location1.000
Cervical3 (8.8)1 (5.9)2 (11.8)
Distal third14 (41.2)7 (41.2)7 (41.2)
Middle third11 (32.4)6 (35.3)5 (29.4)
Proximal third6 (17.6)3 (17.6)3 (17.6)
cTNM stage0.282
II12 (35.3)4 (23.5)8 (47.1)
III22 (64.7)13 (76.5)9 (52.9)
Gastric tube insertion1.000
No23 (67.6)11 (64.7)12 (70.6)
Yes11 (32.4)6 (35.3)5 (29.4)
Follow-up (mo)0.293
Median (IQR)24.5 (15.2-32.5)26.0 (19.0-36.0)